Hi all,
We are pleased to share our March 2021 investor newsletter, which was released to the ASX today.
In this edition you can read the latest update from President and CEO Bob Proulx and learn about the study design of our MagSense HER2 breast cancer Phase 1 study. You can also read a prostate cancer Q&A with IBX Scientific Advisory Board member Professor Lisa Horvarth from Chris O’Brien Lifehouse, and Roger Daly, Monash University.
You can read the newsletter here.
Ann: Imagion Biosystems March 2021 Investor Newsletter, page-2
- There are more pages in this discussion • 97 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IBX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.415M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| IBX (ASX) Chart |
Day chart unavailable